Greatmark Investment Partners, Inc. Biogen Inc. Transaction History

Greatmark Investment Partners, Inc.

$737 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$187.54 - $223.02 $913,132 - $1.09 Million	-4,869 Reduced 27.8%	12,645 $2.58 Million
Q1 2022 Apr 27, 2022	BUY	$193.77 - $244.14 $723,730 - $911,862	3,735 Added 27.11%	17,514 $3.69 Million
Q4 2021 Feb 03, 2022	BUY	$223.92 - $287.77 $995,996 - $1.28 Million	4,448 Added 47.67%	13,779 $3.31 Million
Q3 2021 Nov 02, 2021	BUY	$282.99 - $369.05 $58,295 - $76,024	206 Added 2.26%	9,331 $2.64 Million
Q2 2021 Aug 23, 2021	BUY	$259.0 - $414.71 $720,020 - $1.15 Million	2,780 Added 43.81%	9,125 $3.16 Million
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $454,316 - $532,258	1,870 Added 41.79%	6,345 $1.78 Million
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $76,075 - $114,512	-322 Reduced 6.71%	4,475 $1.1 Million
Q3 2020 Oct 28, 2020	BUY	$264.77 - $305.71 $224,260 - $258,936	847 Added 21.44%	4,797 $1.36 Million
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $315,565 - $417,911	-1,220 Reduced 23.6%	3,950 $1.06 Million
Q1 2020 Apr 29, 2020	SELL	$268.85 - $341.04 $1,344 - $1,705	-5 Reduced 0.1%	5,170 $1.64 Million
Q4 2019 Jan 31, 2020	BUY	$220.06 - $304.07 $149,640 - $206,767	680 Added 15.13%	5,175 $1.54 Million
Q3 2019 Oct 30, 2019	BUY	$217.44 - $243.88 $89,150 - $99,990	410 Added 10.04%	4,495 $1.05 Million
Q2 2019 Aug 05, 2019	BUY	$219.29 - $241.72 $64,690 - $71,307	295 Added 7.78%	4,085 $955,000
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $7,584 - $11,863	35 Added 0.93%	3,790 $896,000
Q4 2018 Feb 01, 2019	BUY	$278.5 - $352.75 $65,447 - $82,896	235 Added 6.68%	3,755 $1.13 Million
Q3 2018 Oct 31, 2018	BUY	$293.51 - $383.83 $13,207 - $17,272	45 Added 1.29%	3,520 $1.24 Million
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $39,915 - $47,571	155 Added 4.67%	3,475 $1.01 Million
Q1 2018 May 04, 2018	SELL	$260.13 - $367.91 $3,901 - $5,518	-15 Reduced 0.45%	3,320 $909,000
Q4 2017 Feb 01, 2018	BUY	$307.64 - $344.58 $292,258 - $327,351	950 Added 39.83%	3,335 $1.06 Million
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $670,542 - $786,310	2,385	2,385 $747,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.

Account